NasdaqGS - Nasdaq Real Time Price USD

Enovix Corporation (ENVX)

Compare
11.28 -0.14 (-1.23%)
At close: December 27 at 4:00:02 PM EST
11.25 -0.03 (-0.27%)
After hours: December 27 at 7:48:49 PM EST

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 4.32M
Earnings -22.54M
Q4'23
Q1'24
Q2'24
Q3'24
-100M
-80M
-60M
-40M
-20M
0
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Analyst Price Targets

10.00
27.25 Average
11.28 Current
100.00 High

Earnings Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 8789
Avg. Estimate -0.18-0.17-0.81-0.64
Low Estimate -0.21-0.2-0.84-0.79
High Estimate -0.15-0.11-0.77-0.42
Year Ago EPS -0.28-0.31-0.88-0.81

Revenue Estimate

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
No. of Analysts 1291213
Avg. Estimate 8.77M6.08M22.15M40.34M
Low Estimate 8M5M21.4M33.1M
High Estimate 9M9M22.73M56.2M
Year Ago Sales 7.38M5.27M7.64M22.15M
Sales Growth (year/est) 18.83%15.32%189.83%82.10%

Earnings History

Currency in USD 12/31/2023 3/31/2024 6/30/2024 9/30/2024
EPS Est. -0.27-0.29-0.23-0.2
EPS Actual -0.28-0.31-0.14-0.17
Difference -0.01-0.020.090.03
Surprise % -4.21%-6.50%38.24%16.86%

EPS Trend

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Current Estimate -0.18-0.17-0.81-0.64
7 Days Ago -0.2-0.2-0.85-0.72
30 Days Ago -0.2-0.2-0.85-0.73
60 Days Ago -0.2-0.2-0.85-0.73
90 Days Ago -0.19-0.21-0.85-0.71

EPS Revisions

Currency in USD Current Qtr. (Dec 2024)Next Qtr. (Mar 2025)Current Year (2024)Next Year (2025)
Up Last 7 Days 4253
Up Last 30 Days 4253
Down Last 7 Days 21--3
Down Last 30 Days 21--3

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
ENVX 35.19%45.62%8.33%20.05%
S&P 500 5.00%12.00%2.10%12.20%

Upgrades & Downgrades

Downgrade Janney Montgomery Scott: Buy to Neutral 10/31/2024
Reiterates Cantor Fitzgerald: Overweight to Overweight 10/30/2024
Reiterates Benchmark: Buy to Buy 10/30/2024
Maintains JP Morgan: Overweight to Overweight 10/22/2024
Maintains Oppenheimer: Outperform to Outperform 8/26/2024
Reiterates Piper Sandler: Overweight to Overweight 8/5/2024

Related Tickers